An alarming situation has been highlighted by the WHO. According to WHO Director-General Tedros Adhanom Ghebreyesus, the rapidly spreading monkeypox outbreak is a global health emergency, the organization’s highest degree of alert.
“I have decided that the global monkeypox outbreak represents a public health emergency of international concern,” WHO Director-General Tedros Adhanom Ghebreyesus said.
The declaration of a public health emergency of international concern improves international cooperation and information exchange.
The declaration was made despite the WHO emergency committee’s inability to agree on whether or not to issue the emergency declaration.
Tedros said the outbreak is spreading rapidly and there is a “clear risk of further international spread.”
Guys who have several sexual partners and have sex with other men are heavily impacted by the monkeypox outbreak. More than 16,000 cases have been reported worldwide, and 2,891 cases have been verified in the United States, according to the Centers for Disease Control.
Monkeypox vaccinations are available, however, there is a shortage of them.
Monkeypox has existed in some areas of central and west Africa for decades, but until May, when officials discovered dozens of infections in Europe, North America, and other places, it was not known to cause significant outbreaks outside of the continent or to spread significantly among people.
Declaring a worldwide emergency indicates that the monkeypox outbreak is an “extraordinary event” that may spread to other nations and necessitates a coordinated international response.
The Covid-19 pandemic, the West African Ebola outbreak in 2014, the Zika virus in Latin America in 2016, and the current campaign to eradicate polio are just a few examples of public health emergencies that the WHO has previously designated emergencies.
191,000 doses have so far been sent to state and local health departments, according to the U.S. Department of Health and Human Services. By the middle of 2023, the federal government will reportedly have close to 7 million doses.
The use of Imnavex, a smallpox vaccine, to treat monkeypox was recommended for clearance by the European Union’s drug authority on Friday.